For Research Use Only. Not for use in diagnostic procedures.
The AVENIO ctDNA Targeted Kit is a next-generation sequencing (NGS) liquid biopsy assay that contains 17 genes, including those in U.S. National Comprehensive Cancer Network (NCCN) Guidelines.1 The Targeted panel may be used for pan-cancer research applications, but is specially optimized for lung cancer and colorectal cancer (CRC). The AVENIO ctDNA Targeted Kit is an efficient tumor profiling solution.
Accurate detection of all four mutation classes with high sensitivity and specificity2,3
View performance data showing >99% sensitivity and PPV for all four classes of mutations from 10-50 ng input DNA using the AVENIO ctDNA Targeted Kit.
The AVENIO ctDNA Targeted Kit is a part of the AVENIO family of NGS oncology assays that include three ctDNA and three corresponding tumor tissue assays. By using the wider family of AVENIO assays, labs can obtain detailed molecular findings across all four mutation classes from plasma or tissue samples.